 New drugs have been developed to treat cancer that work differently than standard chemotherapy drugs. One new class of drugs are called angiogenesis-inhibitors. These drugs attempt to decrease the blood supply to tumors. By doing so, this may limit the tumors source of oxygen and nutrients and prevent the tumor from growing. Bevacizumab is an anti-angiogenic drug. 